Exelixis execs win bonuses for first Cometriq approval; TransCelerate taps R&D vet as new CEO;

 @FierceBiotech: Piramal continues market-access blitz with Abacus takeover. Story | Follow @FierceBiotech

@JohnCFierce: Isis gets $30M up front in a new pact with Biogen to develop antisense drugs. $200M per in biobucks. News | Follow @JohnCFierce

 @RyanMFierce: Wow. Amgen buying deCODE for $415M. Wants to validate disease targets for drug development. | Follow @RyanMFierce

> Exelixis ($EXEL) execs will split $234,000 in bonuses following the first approval for their cancer drug Cometriq (cabozantinib). Story

> R&D vet Dalvir Gill was named CEO of TransCelerate, an industry consortium aimed at collaborating on more efficient R&D processes. Release

> Intrexon has made a bid for the remaining shares of Aqua Bounty Technologies. Story (reg. req.)

Pharma News

@FiercePharma: Pay-for-delay to get Supreme Court consideration. News | Follow @FiercePharma

> Bloomberg: SEC looking at InterMune trades by hedge fund. Story

> Eliquis from Pfizer, Bristol-Myers Squibb shows potential for longer use. Report

> FDA panel says no to high-powered painkiller. Article

Medical Device News

 @FierceMedDev: A Finnish company won CE mark status for noninvasive magnetic stimulation to treat major depression. News | Follow @FierceMedDev

@MarkHFierce: GE has clearly wanted Insightec for a long time. The Israeli company uses MRI-guided ultrasound to ablate tissue. Release | Follow @MarkHFierce

 @DamianFierce: Covance says it's the first global CRO to get GLP certification from Chinese regulators. More | Follow @DamianFierce

> Report: Sanofi considering Bayer's glucose-meter unit. Article

> Brain-stimulation antidepression device gets CE marking. Item

> Vela Diagnostics licenses Swift Biosciences' cancer-detection tech. News

Medical Device News

 @FierceMedDev: A Finnish company won CE mark status for noninvasive magnetic stimulation to treat major depression. News | Follow @FierceMedDev

@MarkHFierce: GE has clearly wanted Insightec for a long time. The Israeli company uses MRI-guided ultrasound to ablate tissue. Release | Follow @MarkHFierce

 @DamianFierce: Covance says it's the first global CRO to get GLP certification from Chinese regulators. More | Follow @DamianFierce

> Report: Sanofi considering Bayer's glucose-meter unit. Article

> Brain-stimulation antidepression device gets CE marking. Item

> Vela Diagnostics licenses Swift Biosciences' cancer-detection tech. News

Biotech IT News

> Consortium sifting through MS data to find new endpoint. Report

> Piramal continues market-access blitz with Abacus takeover. News

> Internet advocate slams pharma's social media moves. Story

> Survey: Pharma's social media, mobile use spreads in 2012. Article

CRO News

> Recipharm bets on analytical development with expansion. More

> Covance notches GLP nod from Chinese regulators. Report

> Alimera taps Quintiles to commercialize Iluvien. News

> AMRI re-ups with GE Healthcare, its largest supply partner. Story

And Finally… Investigators backed by DARPA say that in animal studies a new foam technology was able to arrest bleeding, offering a new approach to treating wounded soldiers. Story

 

Suggested Articles

Disarm Therapeutics signed on Alvin Shih, M.D., the former Retrophin R&D chief who went on to helm Enzyvant, as its full-time CEO.

Pact Pharma launched a phase 1 trial of a technology designed to attack solid tumors with CAR-T cells tailored to individual patients.

Intec's candidate uses a drug delivery system designed to improve on Merck’s Sinemet but was unable to beat the product in a late-phase test.